← Back to signals
TECH
AVOIDBio-Techne Corporation
Health Care
2.88
PEGY ratio
Rank #398
Why This Matters
This stock appears overvalued relative to its growth and dividend yield. Strong projected growth of 194.6% annually over 5 years. Pays a 0.6% dividend yield.
TECH trades at 73.8x earnings against 25.0% capped growth (actual 194.6%) + 0.6% yield (PEGY 2.88). The valuation appears stretched relative to the available growth and income.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 194.6%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-05-29
Valuation
73.8x
P/E Ratio
Growth
194.6%
5yr EPS
Income
0.6%
Div Yield
PEGY Components
PEGY Score2.88
Denominator25.6%
EPS (TTM)$0.70
Market Data
Price$51.68
ExchangeNASDAQ
S&P 500
What Changed
PEGY Score
2.68→2.88(+0.20)
Rank
#387→#398(11 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only